Clinical Trial Update: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium

View source ↗

Summary

Takeda is recruiting adults in Belgium for a study of maribavir to treat post-transplant cytomegalovirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Maribavir (maribavir)

Snippet

Sponsor: Takeda | Conditions: Cytomegalovirus (CMV) | Status: RECRUITING